The Cancer Center at the Texas Tech University Health Sciences Center School of Medicine (TTUHSC SOM) was established in 2008 to provide a center of excellence for cancer research for the School of Medicine and the entire South Plains region.
A major focus of the TTUHSC SOM Cancer Center is conducting laboratory and clinical research that develops new anti-cancer drugs for both adults and children with difficult-to-treat cancers. The Cancer Center hosts the Operations Center for a clinical consortium, the South Plains Oncology Consortium that conducts early phase clinical trials in adults and children with cancer. The Cancer Center also hosts the Operations Center and laboratories for the Texas Cancer Cell Repository, a Cancer Prevention & Research Institute of Texas (CPRIT)-funded collaboration between a number of institutions to establish, bank, and distribute cancer cells from patients that have been established to grow in the laboratory or in special mice for use in studying the cancer biologies and novel therapies. The Cancer Center is the regional site for the Clinical Trials Network of Texas and the Texas Cancer Research Biobank. Through these consortia TTUHSC works closely with other institutions in Texas and beyond to carry out clinical and translational laboratory research in cancer drug development.
The TTUHSC SOM Cancer Center also hosts several national resource laboratories that support clinical and translational research for childhood cancer:
- The In Vitro (cell culture) drug testing lab for the National Cancer Institute Pediatric Precllinical Testing Program (PPTP)
- The Children's Oncology Group (COG) Cell Line and Xenograft Repository
- The Children's Oncology Group (COG) Ewing's Family Tumors Preclinical Drug Testing Laboratory
In the Spotlight
- Nov 15, 2011: Cancer Center members attended the Cancer Prevention & Research Institute of Texas (CPRIT) "Innovations in Cancer Prevention and Research Conference" in Austin Texas and presented 5 scientific abstracts. Dr. Reynolds was a member of the CPRIT Foundation 3rd annual Breakthrough Roundtable meeting which discussed "Molecular Diagnostics in Cancer".